These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1066 related items for PubMed ID: 27842860

  • 1. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
    Nguyen S, Chalandon Y, Lemarie C, Simon S, Masson D, Dhedin N, Suarez F, Renaud B, Charbonnier A, Yafour N, François S, Duléry R, Blaise D, Yakoub-Agha I, Rubio MT.
    Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
    [Abstract] [Full Text] [Related]

  • 2. [Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Dubois V, Amokrane K, Beguin Y, Bruno B, Chevallier P, Delbos F, Devillier R, Giannoli C, Guidicelli G, Harif M, Loiseau P, Rouzaire PO, Varlet P, Yakoub-Agha I, Nguyen S.
    Bull Cancer; 2020 Jan; 107(1S):S72-S84. PubMed ID: 31586527
    [Abstract] [Full Text] [Related]

  • 3. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
    Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, Savani BN, Smith SM, Sureda AM, Waller EK, Jaglowski S, Herrera AF, Armand P, Salit RB, Wagner-Johnston ND, Fuchs E, Bolaños-Meade J, Hamadani M.
    J Clin Oncol; 2016 Sep 10; 34(26):3141-9. PubMed ID: 27269951
    [Abstract] [Full Text] [Related]

  • 4. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
    Bashey A, Solomon SR.
    Bone Marrow Transplant; 2014 Aug 10; 49(8):999-1008. PubMed ID: 24842530
    [Abstract] [Full Text] [Related]

  • 5. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, Morris LE, Bashey A.
    Biol Blood Marrow Transplant; 2015 Jul 10; 21(7):1299-307. PubMed ID: 25797174
    [Abstract] [Full Text] [Related]

  • 6. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X, Liu D.
    Clin Transpl; 2011 Jul 10; ():237-45. PubMed ID: 22755417
    [Abstract] [Full Text] [Related]

  • 7. [Second allogeneic hematopoietic stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
    Yafour N, Couturier MA, Azarnoush S, Girault S, Hermet E, Masouridi Levrat S, Schmidt A, Michallet M, Etancelin P, Guillaume T, Malard F, Sirvent A, Yakoub-Agha I, Poiré X.
    Bull Cancer; 2019 Jan 10; 106(1S):S40-S51. PubMed ID: 30409466
    [Abstract] [Full Text] [Related]

  • 8. [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
    Yu JP, Cao S, Xin N, An XM, Qi J, Ren XB.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct 10; 15(5):1013-8. PubMed ID: 17956681
    [Abstract] [Full Text] [Related]

  • 9. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A, Yañez R, Colmenero I, Aldea M, Rubio A, Bueren JA, Lamana ML.
    Cell Transplant; 2013 Oct 10; 22(8):1381-94. PubMed ID: 23044223
    [Abstract] [Full Text] [Related]

  • 10. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
    Blaise D, Fürst S, Crocchiolo R, El-Cheikh J, Granata A, Harbi S, Bouabdallah R, Devillier R, Bramanti S, Lemarie C, Picard C, Chabannon C, Weiller PJ, Faucher C, Mohty B, Vey N, Castagna L.
    Biol Blood Marrow Transplant; 2016 Jan 10; 22(1):119-24. PubMed ID: 26341397
    [Abstract] [Full Text] [Related]

  • 11. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
    Yahng SA, Kim JH, Jeon YW, Yoon JH, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Kim HJ.
    Biol Blood Marrow Transplant; 2015 Jan 10; 21(1):119-29. PubMed ID: 25300871
    [Abstract] [Full Text] [Related]

  • 12. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ.
    Biol Blood Marrow Transplant; 2015 Jun 10; 21(6):1110-6. PubMed ID: 25698612
    [Abstract] [Full Text] [Related]

  • 13. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
    Fu H, Xu L, Liu D, Liu K, Zhang X, Chen H, Chen Y, Han W, Wang Y, Wang J, Wang F, Huang X.
    Biol Blood Marrow Transplant; 2014 Aug 10; 20(8):1176-82. PubMed ID: 24747336
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X, Liu L, Xie Z, Dong C, Zhao L, Zhang J, Gu J, Zhu HH.
    Crit Rev Oncol Hematol; 2019 Jan 10; 133():120-128. PubMed ID: 30661648
    [Abstract] [Full Text] [Related]

  • 15. Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial.
    Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, Morris LE, Bashey A.
    Biol Blood Marrow Transplant; 2012 Dec 10; 18(12):1859-66. PubMed ID: 22863841
    [Abstract] [Full Text] [Related]

  • 16. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N, Greco R, Crucitti L, Morelli M, Giglio F, Levati G, Assanelli A, Carrabba MG, Bellio L, Milani R, Lorentino F, Stanghellini MT, De Freitas T, Marktel S, Bernardi M, Corti C, Vago L, Bonini C, Ciceri F, Peccatori J.
    Biol Blood Marrow Transplant; 2015 Aug 10; 21(8):1506-14. PubMed ID: 26001696
    [Abstract] [Full Text] [Related]

  • 17. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L.
    Ann Med; 2008 Aug 10; 40(6):444-55. PubMed ID: 18608121
    [Abstract] [Full Text] [Related]

  • 18. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, Bregante S, Van Lint MT, Varaldo R, Ghiso A, Gobbi M, Carella AM, Signori A, Galaverna F, Bacigalupo A.
    Biol Blood Marrow Transplant; 2014 Oct 10; 20(10):1573-9. PubMed ID: 24910379
    [Abstract] [Full Text] [Related]

  • 19. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.
    Gorin NC, Labopin M, Piemontese S, Arcese W, Santarone S, Huang H, Meloni G, Ferrara F, Beelen D, Sanz M, Bacigalupo A, Ciceri F, Mailhol A, Nagler A, Mohty M, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Haematologica; 2015 Apr 10; 100(4):558-64. PubMed ID: 25637051
    [Abstract] [Full Text] [Related]

  • 20. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Gauthier J, Castagna L, Garnier F, Guillaume T, Socié G, Maury S, Maillard N, Tabrizi R, Marchand T, Malfuson J, Gac A, Gyan E, Mercier M, Béguin Y, Delage J, Turlure P, Marçais A, Nguyen S, Dulery R, Bay J, Huynh A, Daguindau E, Cornillon J, Régny C, Michallet M, Peffault de Latour R, Yakoub-Agha I, Blaise D.
    Bone Marrow Transplant; 2017 May 10; 52(5):689-696. PubMed ID: 28067872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.